NCT02636517
Fecal Microbiome Transplant
Enrolling by Invitation
PHASE1Ages 3–21InterventionalTreatmentJudith KelsenInvestigator-initiated
~250 participants
Updated 2026-04-15 on ClinicalTrials.gov
What's tested:Fecal Microbiota Transplant
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of subjects with a recurrence of C. difficile (CDI)
Measured over 7 days
Conditions
Where it's being run
1 sites across 1 statesPennsylvania1
Study leadership
- Judith Kelsen, MD · PRINCIPAL_INVESTIGATOR · Children's Hospital of Philadelphia
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Number of subjects with a recurrence of C. difficile (CDI)7 days
The hypothesis is that FMT will be an effective therapy for patients with IBD and CDI, resulting in resolution of symptoms as compared to historical controls on antibiotic therapy.